| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |